Covered recipient · General Payments record
JOANNA L MARCO
Allopathic & Osteopathic Physicians Internal Medicine Rheumatology
General Payments · PY2018–2024
$754.16
- Reported across 29 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $278.59 | 18 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $154.14 | 12 |
| PFIZER INC. | $50.91 | 2 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $49.18 | 3 |
| GlaxoSmithKline, LLC. | $24.36 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (18)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $26.86 | 01/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104964144 | CMS |
| ABBVIE INC. | $2.49 | 02/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104964146 | CMS |
| ABBVIE INC. | $3.05 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104964148 | CMS |
| ABBVIE INC. | $24.87 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104964150 | CMS |
| ABBVIE INC. | $3.65 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104964152 | CMS |
| ABBVIE INC. | $16.50 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104964154 | CMS |
| ABBVIE INC. | $0.87 | 07/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104964156 | CMS |
| ABBVIE INC. | $0.95 | 08/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104964158 | CMS |
| ABBVIE INC. | $13.37 | 09/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104964160 | CMS |
| ABBVIE INC. | $12.86 | 10/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104964162 | CMS |
| ABBVIE INC. | $20.22 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104964164 | CMS |
| ABBVIE INC. | $28.45 | 12/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104964166 | CMS |
| GlaxoSmithKline, LLC. | $24.36 | 08/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116452061 | CMS |
| Novartis Pharmaceuticals Corporation | $19.32 | 09/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086988086 | CMS |
| Novartis Pharmaceuticals Corporation | $15.00 | 11/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086988088 | CMS |
| Novartis Pharmaceuticals Corporation | $14.86 | 12/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086988090 | CMS |
| PFIZER INC. | $24.63 | 08/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131855500 | CMS |
| PFIZER INC. | $26.28 | 10/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132074939 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.